Tele: 561.316.3330
Breaking Medical Device News

Saturday, October 16, 2021
HomeEXECUTIVESNemours Children's Health System Announces New Chief Executive of Delaware Valley Operations...

Nemours Children’s Health System Announces New Chief Executive of Delaware Valley Operations – Mark Mumford

After a highly competitive national search, Nemours Children’s Health System has announced the appointment of Mark Mumford as Chief Executive of Delaware Valley Operations, effective September 1, 2020.

Mumford will serve as a member of the Executive Cabinet and report to President and Chief Executive Officer R. Lawrence Moss, MD.  He will be based in Wilmington, DE at the Nemours Alfred I. duPont Hospital for Children.

In this role, Mark Mumford will be responsible for all clinical operations at Nemours/Alfred I. duPont for Children and Nemours duPont Pediatrics including ambulatory surgery centers and all primary, specialty, and urgent care practices, and prevention efforts in Delaware, Pennsylvania, New Jersey and Maryland.

“Mark is a multifaceted and visionary leader who is deeply committed to the welfare of all children and has great experience helping complex organizations accomplish strategic and operational objectives,” said Moss.  “Mark is exceptional at versatility in balancing growth and efficiency while nurturing cultural pillars that support sustainability. I look forward to his leadership in the Delaware Valley as well as across the enterprise.”

Since 2013, Mumford has served as the Senior Vice President of Finance and Chief Financial Officer of Cincinnati Children’s Hospital. Prior, Mumford held executive and senior financial positions with corporations such as P.F. Chang’s China Bistro, PetSmart, and MicroAge.  Mumford holds a B.S. in Accounting from Arizona State University.

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Stay Connected

spot_img

Don't Miss

Ganymed Robotics Awarded a €2.5M Grant from the EC through the EIC Accelerator Program

Ganymed Robotics is developing a radically new approach to surgical robotics by combining computer vision, a branch of artificial intelligence, and mechatronics.

Global Healthcare Exchange Announces Acquisition of Explorer Surgical

Explorer Surgical will operate as a wholly-owned subsidiary of GHX.

Arlington Scientific Broadens Product Portfolio and Further Expands its Product Offering Through the acquisition of Non-Mammalian Blocking Buffers

Arlington Scientific, Inc. (ASI) is pleased to announce that it has acquired the non-mammalian blocking buffer product line from Clark McDermith, former owner of...

Laborie Medical Technologies Acquires Pelvalon

Laborie was represented by Piper Sandler (financial advisor) and Simpson Thacher & Bartlett LLP (legal advisor). Pelvalon was represented by J.P. Morgan Securities LLC (financial advisor) and Dorsey & Whitney LLP (legal advisor).

Herculite Products, Inc. Promotes Two Employees to New Roles

Paul Flaherty Chief Strategy Officer and Marco Angelone is being promoted to the role of Chief Financial Officer.

Prof. Joseph Kvedar Added to the Sweetch Advisory Board Member

Prof. Josdeph Kvedar is the current chair of the board at the American Telemedicine Association (ATA), formerly VP of Connected Health at Mass-Gen Brigham, co-chair of the American Medical Association (AMA) Digital Medicine Payment Advisory Group, and author of The Internet of Healthy Things and The New Mobile Age.

Sid Bala Named President of HealthChampion

Sid Bala is the former president and chief executive officer of alligatortek, a custom software applications company that was acquired by HealthChampion in 2020 where he led them for 27 years after he founded the business

Cochlear Announces FDA Approval and Clearance of first-of-its-kind Remote Care Capabilities for Nucleus and Baha Systems

The FDA approval for the cochlear implant solution and FDA clearance for the Baha solution is the first step in commercializing the product offering, anticipated spring 2022, and complement Cochlear's existing Remote Care offerings.

By using this website you agree to accept Medical Device News Magazine Privacy Policy